Pinealon Research: What 48 Studies Show (2026) | RetatrutideCompare

Pinealon — 48 studies indexed on PubMed. Proposed neuroprotective and anti-aging effects via gene expression modulation in pineal and cortical tissues. Half-life: Minutes in plasma. FDA status: Not FDA-approved.

PubMed search-result count last fetched 2026-06-18. Records may include reviews, laboratory work, and animal studies; this is not a clinical trial count or a measure of efficacy.

Inspect the PubMed query and results

How many studies have been published on Pinealon?

There are approximately 48 studies indexed on PubMed that mention Pinealon (EDR, Glu-Asp-Arg), based on a search last updated 2026-06-18.

Is Pinealon FDA-approved?

FDA status: Not FDA-approved.

How does Pinealon work?

Proposed neuroprotective and anti-aging effects via gene expression modulation in pineal and cortical tissues.

Proposed neuroprotective and anti-aging effects via gene expression modulation in pineal and cortical tissues.

Reference facts

Also known as
EDR, Glu-Asp-Arg
Category
Khavinson Bioregulators
Mechanism of action
Proposed neuroprotective and anti-aging effects via gene expression modulation in pineal and cortical tissues.
Targets
Neural gene expression (proposed)
Indications under research or approved
Russian neurogerontology research
Regulatory status (reference entry)
Not FDA-approved
Half-life
Minutes in plasma
Sequence
EDR
Sequence notes
Tripeptide bioregulator from the Khavinson series, targeting CNS / pineal tissue.
Molecular weight (Da)
419
First reported
2003

Primary References

Explore research articles about Pinealon

This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.